Anna Marie Byrne, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2116 Craig Rd, Eau Claire, WI 54701 Phone: 715-858-4500 |
Andrew J Strope, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 517 E Clairemont Ave, Eau Claire, WI 54701 Phone: 715-855-0408 |
Kasey Kruse, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Lori M Stress, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1262 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-858-4610 |
Mrs. Holli Ann Kloss, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Mr. Paul F Greene, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Jessica Marie Ortiz-peterson, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Mr. Jeffrey K Anlauf, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2120 Heights Dr, Eau Claire, WI 54701 Phone: 715-832-1681 |
Nicole L Marquardt, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Mrs. Erin Rebecca Hoelscher, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3656 Mall Dr, Eau Claire, WI 54701 Phone: 715-552-1035 |
Katie Geisdorf, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-3311 |
Dr. Adeniyi Paul Adenote, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
Ms. Renee A Weber, MS PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3004 Golf Rd, Suite 100, Eau Claire, WI 54701 Phone: 715-834-4516 Fax: 715-834-0552 |
Kathleen Marie Litscher, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4210 Southtown Dr, Eau Claire, WI 54701 Phone: 715-839-9266 |
Dr. Samuel Steinberger, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 |
Georgia P Davis, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 |
Caitlyn Behling, PT, DPT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3631 Goldridge Rd, Eau Claire, WI 54701 Phone: 715-563-0722 |
Kevan John Laporte, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 517 E. Clairemont Avenue, Eau Claire, WI 54701 Phone: 715-855-0408 Fax: 715-855-0409 |
Stephanie F Kohlhepp, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1262 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-858-4610 |
Glynna Erin Godfrey, PT,DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 |
News Archive
Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.
Diabetic foot reconstruction using free flaps has high success and survival rates, say researchers.
Are e-cigarettes an important smoking cessation tool or an emerging public health concern?
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Bristol-Myers Squibb Company today announced results from a Phase II study in which treatment with an all-oral, dual direct-acting antiviral (DAA) regimen of daclatasvir, an investigational NS5A replication complex inhibitor, and asunaprevir, an investigational NS3 protease inhibitor, achieved undetectable viral load 24 weeks post-treatment (SVR24) in 77% (33/43) of difficult-to-treat genotype 1b hepatitis C (HCV) patients.
› Verified 1 days ago